- Home
- NIE vs PSNL Comparison
NIE vs PSNL Comparison
Compare NIE & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIE
- PSNL
- Stock Information
- Founded
- NIE 2007
- PSNL 2011
- Country
- NIE United States
- PSNL United States
- Employees
- NIE N/A
- PSNL N/A
- Industry
- NIE Investment Managers
- PSNL Medical Specialities
- Sector
- NIE Finance
- PSNL Health Care
- Exchange
- NIE Nasdaq
- PSNL Nasdaq
- Market Cap
- NIE 660.9M
- PSNL 580.3M
- IPO Year
- NIE N/A
- PSNL 2019
- Fundamental
- Price
- NIE $23.94
- PSNL $6.37
- Analyst Decision
- NIE
- PSNL Strong Buy
- Analyst Count
- NIE 0
- PSNL 5
- Target Price
- NIE N/A
- PSNL $8.00
- AVG Volume (30 Days)
- NIE 70.5K
- PSNL 1.9M
- Earning Date
- NIE 01-01-0001
- PSNL 08-06-2025
- Dividend Yield
- NIE 9.04%
- PSNL N/A
- EPS Growth
- NIE N/A
- PSNL N/A
- EPS
- NIE N/A
- PSNL N/A
- Revenue
- NIE N/A
- PSNL $85,694,000.00
- Revenue This Year
- NIE N/A
- PSNL $0.45
- Revenue Next Year
- NIE N/A
- PSNL $25.75
- P/E Ratio
- NIE N/A
- PSNL N/A
- Revenue Growth
- NIE N/A
- PSNL 15.57
- 52 Week Low
- NIE $18.61
- PSNL $1.52
- 52 Week High
- NIE $22.47
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- NIE 62.81
- PSNL 51.74
- Support Level
- NIE $23.71
- PSNL $6.52
- Resistance Level
- NIE $24.05
- PSNL $7.32
- Average True Range (ATR)
- NIE 0.26
- PSNL 0.52
- MACD
- NIE 0.02
- PSNL -0.06
- Stochastic Oscillator
- NIE 89.59
- PSNL 25.85
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.